Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 13.25
-0.05 (-0.38%)
Sep 18, 2026, 1:28 PM CET
Navamedic ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 318 | 571 | 454 | 637 | 601 | 556 | |
Market Cap Growth | -17.48% | 25.74% | -28.72% | 5.92% | 8.19% | 90.28% |
Enterprise Value | 448 | 831 | 534 | 720 | 625 | 561 |
Last Close Price | 13.25 | 23.80 | 25.27 | 36.09 | 34.32 | 33.43 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 20.43 | 899.28 |
Forward PE | 161.39 | 59.50 | 17.12 | 15.07 | 16.37 | - |
PS Ratio | 0.55 | 1.01 | 0.85 | 1.24 | 1.57 | 2.00 |
PB Ratio | 1.04 | 1.71 | 2.10 | 3.10 | 2.87 | 3.68 |
P/TBV Ratio | - | - | - | - | 7.67 | 8.84 |
P/FCF Ratio | 25.07 | 24.60 | 12.60 | - | 38.32 | - |
P/OCF Ratio | 20.87 | 22.31 | 11.54 | 292.27 | 33.51 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.78 | 1.47 | 1.01 | 1.41 | 1.64 | 2.02 |
EV/EBITDA Ratio | 8.92 | 18.63 | 12.30 | 14.65 | 12.60 | 34.77 |
EV/EBIT Ratio | 106.82 | 51.11 | 16.81 | 18.17 | 14.07 | 49.01 |
EV/FCF Ratio | 35.32 | 35.80 | 14.83 | - | 39.84 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.60 | 0.62 | 0.55 | 0.74 | 0.28 | 0.31 |
Debt / EBITDA Ratio | 3.64 | 4.37 | 2.55 | 2.96 | 1.14 | 2.57 |
Debt / FCF Ratio | 14.44 | 8.97 | 3.29 | - | 3.74 | - |
Net Debt / Equity Ratio | 0.43 | 0.40 | 0.38 | 0.56 | 0.02 | -0.04 |
Net Debt / EBITDA Ratio | 2.76 | 3.01 | 1.87 | 2.34 | 0.07 | -0.37 |
Net Debt / FCF Ratio | 10.26 | 5.78 | 2.26 | -6045.00 | 0.22 | 2.96 |
Asset Turnover | 1.01 | 0.94 | 1.09 | 1.15 | 1.07 | 0.94 |
Inventory Turnover | 3.24 | 3.51 | 3.48 | 3.39 | 3.09 | 3.21 |
Quick Ratio | 0.74 | 0.69 | 0.66 | 0.49 | 0.90 | 0.78 |
Current Ratio | 1.47 | 1.45 | 1.42 | 1.11 | 1.93 | 1.51 |
Return on Equity (ROE) | -8.86% | -8.55% | -2.60% | -6.59% | 16.31% | 0.44% |
Return on Assets (ROA) | 0.46% | 1.68% | 4.08% | 5.57% | 7.79% | 2.43% |
Return on Invested Capital (ROIC) | 0.95% | 4.24% | 10.29% | 14.86% | 17.17% | 2.33% |
Return on Capital Employed (ROCE) | 0.80% | 2.90% | 9.70% | 12.50% | 17.30% | 5.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -7.29% | -4.12% | -1.21% | -2.15% | 4.90% | 0.11% |
FCF Yield | 3.99% | 4.06% | 7.94% | -0.00% | 2.61% | -0.36% |
Buyback Yield / Dilution | -27.84% | -8.91% | -1.24% | -1.48% | -3.60% | -13.61% |